Clinical Trial Update: A/H5N1/LT Dose Ranging Study [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial of an H5N1 influenza vaccine completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pandemic Influenza

Drugs mentioned

• A/H5N1/LT

Snippet

Sponsor: Intercell USA, Inc. | Conditions: Pandemic Influenza | Phase 2 | Status: COMPLETED | Results posted: 2014-03-13